Frank Yocca

Insider Reports History

Entity
Individual
Location
780 East Main Street, C/O Bioxcel Therapeutics, Inc., Branford, CT
Signature
/s/ Richard Steinhart, Attorney-in-Fact for Frank Yocca
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Frank Yocca:

Stock Role Class Num Shares Value Price $ Report Date Ownership
BioXcel Therapeutics, Inc. Chief Scientific Officer Common Stock 28.3K $15.6K $0.55 Oct 3, 2024 Direct
BioXcel Therapeutics, Inc. Chief Scientific Officer Restricted Stock Units 5.63K $3.88K $0.69 Sep 15, 2024 Direct

Insider Reports Filed by Frank Yocca

Symbol Company Period Transactions Value $ Form Type Date Filed Role
BTAI BioXcel Therapeutics, Inc. Sep 17, 2024 2 -$3.95K 4 Oct 3, 2024 Chief Scientific Officer
BTAI BioXcel Therapeutics, Inc. Sep 14, 2024 5 -$245 4 Sep 17, 2024 Chief Scientific Officer
BTAI BioXcel Therapeutics, Inc. Jun 14, 2024 5 -$476 4 Jun 18, 2024 Chief Scientific Officer
BTAI BioXcel Therapeutics, Inc. Mar 14, 2024 5 -$2.81K 4 Apr 8, 2024 Chief Scientific Officer
BTAI BioXcel Therapeutics, Inc. Dec 14, 2023 2 $0 4 Dec 18, 2023 Chief Scientific Officer
BTAI BioXcel Therapeutics, Inc. Sep 14, 2023 2 $0 4 Sep 18, 2023 Chief Scientific Officer
BTAI BioXcel Therapeutics, Inc. Jun 14, 2023 2 $0 4 Jun 16, 2023 Chief Scientific Officer
BTAI BioXcel Therapeutics, Inc. Mar 14, 2023 5 -$19.4K 4 Mar 16, 2023 Chief Scientific Officer
BTAI BioXcel Therapeutics, Inc. Jan 20, 2023 1 -$1.5M 4 Jan 24, 2023 Chief Scientific Officer
BTAI BioXcel Therapeutics, Inc. Mar 14, 2022 2 $0 4 Mar 16, 2022 Chief Scientific Officer